Le Lézard
Classified in: Health, Science and technology
Subject: Conference

Organoids, Spheroids & Organs-on-Chips Conference 2024: Technologies to Commercialization, Innovations in Flow Cytometry and Extracellular Vesicles (Laguna Hills, California - November 18-20, 2024) - ResearchAndMarkets.com


The "Organoids, Spheroids & Organs-on-Chips 2024" conference has been added to ResearchAndMarkets.com's offering.

Organoids, Spheroids and Organs-on-Chips 2024 Conference focuses on an important and expanding field wherein cells are being assembled using Microfluidics and Lab-on-a-Chip technologies in a functionally-relevant manner. These clusters of "assembled cells" have functional significance and can mimic in vivo organ structure.

Liver cells assembled on-board chips in a physiologically-relevant architecture using microfluidics can, for instance, be utilized for toxicity screening and the ability to assemble organ fragments ex vivo can provide an exquisite means to reconstruct biological processes (both physiological and pathological) "in a dish" or "on a chip." A number of chips such Lung-on-a-Chip, Brain-on-a-Chip, Gut-on-a-Chip, Marrow-on-a-Chip, Bone-on-a-Chip, Nerve-on-a-Chip amongst others have been built and will be presented and explored at this conference. We will also focus on "disease-on-a-chip", cancer-on-a-chip, immune system-on-a-chip.

Registered delegates will have full access to the co-located and concurrent conference tracks to mix-and-match presentations and maximize networking:

There are ample opportunities for networking, partnering and business development and this ensures a very cost-effective conference trip.

Agenda Topics

Speakers

Holger Schmidt

Narinder Kapany Professor of Electrical Engineering, University of California-Santa Cruz

Roger Kamm

Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)

Herve Tiriac

Assistant Researcher, University of California-San Diego

Steven C. George

Edward Teller Distinguished Professor and Chair, Department of Biomedical Engineering, University of California-Davis

Kevin Healy

Jan Fandrianto and Selfia Halim Distinguished Professorship in Engineering, University of California, Berkeley

Alysson Muotri

Professor, Director of the Stem Cell Program, University of California-San Diego

Alice Soragni

Assistant Professor, University of California Los Angeles

For more information about this conference visit https://www.researchandmarkets.com/r/5gnvhm

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


These press releases may also interest you

at 02:03
Barrington James, a global leader in Life Science Recruitment, proudly announces the acquisition of S3 Science Recruitment, a firm renowned for its expertise in drug discovery, medical research, and the broader field of life sciences. Terms of the...

at 02:00
July 3, 2024 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of...

at 01:39
Hansa Biopharma, "Hansa" , will publish its interim report for January-June 2024 on July 18, 2024. Interested parties may join the Company's quarterly conference call on the same date at 14:00 CEST/8:00 AM EST. The event will be hosted by Søren...

at 01:05
Regulatory News: BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced artificial intelligence (AI) to accelerate biopharma drug discovery, today announces a change to its Executive Leadership Team...

at 00:15
In the news release, AbbVie, Inc.'s Zymaxid tm Implicated in Product Liability Lawsuit Due to Risk of Serious Injury and Death, issued 02-Jul-2024 by Wormington & Bollinger over PRWeb, the source of the release should be "Wormington & Bollinger"...

at 00:00
Author David W. Treaster shares a Christian-based plan that can supplement a cancer patient's medical treatment plan in God Power Cancer Healing Plan: Spiritual Component ($15.99, paperback, 9781662899942; $7.99, e-book, 9781662899959). As long as...



News published on and distributed by: